 |
|
|
|
Hollywood, Florida
Saturday, July 17, 2010
|
|
New York, New York
Saturday, July 24, 2010 |
|
|
Activity Overview | This unique series of two live, one-day meetings will provide expert reviews of the most meaningful and practice-changing data in the field of oncology and hematology presented at the Oncology Annual Meeting in Chicago and other major society meetings held throughout 2010. In addition to didactic lectures, the format of the meeting also includes interactive “Smartest Oncologist/Hematologist Quizzes.”
|
Course Agenda |
| 7.00 AM |
Registration & continental breakfast |
| 8.00 AM |
Welcome and introduction |
| 8.10 AM |
Smartest Oncologist/Hematologist Quiz |
| 8.20 AM |
Lung cancer
|
| 9.00 AM |
Smartest Oncologist/Hematologist Quiz
|
| 9.10 AM |
Genitourinary cancers
|
| 9.50 AM |
Break |
| 10.10 AM |
Smartest Oncologist/Hematologist Quiz |
| 10.20 AM |
Breast cancer
|
| 11.00 AM |
Smartest Oncologist/Hematologist Quiz
|
| 11.10 AM |
Gastrointestinal cancers
|
| 11.50 AM |
Smartest Oncologist/Hematologist Quiz
|
| 12.00 PM |
Gynecologic cancers
|
| 12.40 PM |
Lunch |
| 1.30 PM |
Smartest Oncologist/Hematologist Quiz |
| 1.40 PM |
Lymphomas |
| 2.10 PM |
Leukemias, myelodysplasia, and transplantation |
| 2.40 PM |
Myeloma and plasma cell disorders |
| 3.10 PM |
Concluding remarks |
| 3.15 PM |
Adjourn |
|
Confirmed Faculty |
Kenneth Anderson, MD, FACP
Dana-Farber Cancer Institute
Boston, Massachusetts
Susana Campos, MD, MPH
Dana-Farber Cancer Institute
Boston, Massachusetts
Mary Cianfrocca, DO
Northwestern University
Chicago, Illinois
Robert Dreicer, MD, FACP
Cleveland Clinic
Cleveland, Ohio
Christopher Flowers, MD, MS
Emory University
Atlanta, Georgia
Irene Ghobrial, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
Ramaswamy Govindan, MD
Washington University School of Medicine
St. Louis, Missouri |
David Ilson, MD, PhD
Memorial Sloan-Kettering Cancer Center
New York, New York
Elias Jabbour, MD
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas
Hagop Kantarjian, MD
The University of Texas
M. D. Anderson Cancer Center
Houston, Texas
Fadlo Khuri, MD
Emory University
Atlanta, Georgia
Matthew Milowsky, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Alexi Wright, MD
Dana-Farber Cancer Institute
Boston, Massachusetts
|
|
Faculty by Location |
Florida
Mary Cianfrocca, DO
Christopher Flowers, MD, MS
Irene Ghobrial, MD
David Ilson, MD, PhD
Hagop Kantarjian, MD
Fadlo Khuri, MD
Matthew Milowsky, MD
Alexi Wright, MD |
New York
Kenneth Anderson, MD
Susana Campos, MD, MPH
Mary Cianfrocca, DO
Robert Dreicer, MD
Christopher Flowers, MD, MS
Ramaswamy Govindan, MD
David Ilson, MD, PhD
Elias Jabbour, MD
|
|
Venue Information |
Hollywood, Florida
The Westin Diplomat
3555 South Ocean Drive
Hollywood, Florida 33019
954.602.6000
|
New York, New York
The Westin New York at Times Square
270 West 43rd Street
New York, New York 10036
212.201.2700 |
|
Fee for Activity and Registration | Physicians/Nurses
- Physician preregistration: $75.00
- Physician on-site registration: $100.00
- Nurse preregistration: $35.00*
- Nurse on-site registration: $50.00*
*Supporting documentation of eligibility may be required.
Preregistration will close on the following days for each meeting:
- Florida – July 14, 2010
- New York – July 21, 2010
After preregistration closes, the price will increase to the on-site rate. Attendees may still register online or on site the morning of the meeting.
Residents/Fellows
Residents/Fellows are eligible for complimentary registration. Please contact oncologyreviews@primeoncology.org for more information.
The registration fee includes all activity materials, continental breakfast, lunch, and refreshment breaks. prIME Oncology does not accept liability for travel, accommodations, or any other costs incurred by registrants.
Cancellation/Substitutions Policy
The registration fee is nonrefundable. Substitutions will be accepted up to one week prior to the meeting date with written notice.
|
Target Audience, Statement of Need, and Educational Objectives | Target Audience
This educational activity is intended for medical oncologists, radiation oncologists, surgical oncologists, pathologists, radiologists, and other translational-oriented laboratory scientists involved and/or interested in the multidisciplinary care of patients with cancer.
Statement of Need
As the rate at which clinical data are released increases and the numbers of therapeutic options grow, it is important for practicing oncologists and hematologists to stay abreast of these advances. Many community oncologists, hematologists, and other physicians involved in the management of hematologic malignancies and solid tumors do not attend major society meetings and, likewise, those who do, find the size and scope to be so broad and intensive that they require summaries of important data for ease of application to their daily practices. In order for rapid clinical progress to have a direct and immediate impact on patients’ lives, the newest findings must be readily applied by the practices of community oncologists and hematologists. In addition, the data presented at large clinical conferences are typically not framed in the context of the clinical practice of community oncologists/hematologists. prIME Oncology presents “Oncology Reviews Unlimited—A Critical Appraisal of Data from the 2010 Oncology Annual Meeting,” to review, summarize, and interpret the most clinically significant data released in an effort to meet this need.
Educational Objectives
Upon completion of this educational activity, participants should be better able to:
• Discuss challenging issues in the management of patients with breast cancer, including neoadjuvant therapy, HER2-positive and triple-negative disease, and bone health.
• Describe recent advances in the treatment of renal cell carcinoma, bladder cancer, and prostate cancer, and evaluate clinical trial data supporting the use of novel agents in the management of patients with genitourinary malignancies.
• Integrate multimodality treatment strategies, including radiation therapy, chemotherapy, and targeted therapy, into the management of patients with lung cancer.
• Evaluate contemporary therapeutic approaches for the management of patients with gastrointestinal cancers, and review the latest advances in improving survival rates and quality of life in this patient population.
• Recommend state-of-the-art treatment strategies for patients with hematologic malignancies.
• Integrate novel findings in the management of solid tumors into clinical practice.
|
Accreditation Statement, Credit Statement, Disclosure Statement, and Americans with Disabilities Act | Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The School of Medicine of The University of North Carolina at Chapel Hill and prIME Oncology. The School of Medicine of The University of North Carolina at Chapel Hill is accredited by the ACCME to provide continuing medical education for physicians.
Credit Statement
The School of Medicine of The University of North Carolina at Chapel Hill designates this educational activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Statement
In accordance with the ACCME Criteria and Standards, everyone involved in planning or presenting this educational activity will be required to disclose any relevant financial relationships with commercial interests in the healthcare industry, and this information will be made available to participants at the start of the activity. In addition, speakers who incorporate information about off-label or investigational use of drugs or devices will be asked to disclose that information at the beginning of their presentation.
Americans with Disabilities Act
The University of North Carolina at Chapel Hill and prIME Oncology are committed to equality of educational opportunity and do not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, veteran’s status, or sexual orientation. If you require reasonable accommodations for a disability in order to participate fully in this continuing education activity, please call 678.892.1358 or email Michael Checkoway at michael.checkoway@oncoservices.com no later than July 2.
|
|
|
|
Sponsorship and Support | This activity is jointly sponsored by The School of Medicine of The University of North Carolina at Chapel Hill and prIME Oncology.
This activity is supported by educational grants from:
|
|
|
|
|
|
|
|
|
|
|
|
